Cargando…

Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism

INTRODUCTION: The mechanism by which intra-articular injection of hyaluronan (HA) ameliorates joint pathology is unknown. Animal studies have shown that HA can reduce synovial activation, periarticular fibrosis and cartilage erosion; however, its specific effects on the different cell types involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun, Gorski, Daniel J, Anemaet, Wendy, Velasco, Jennifer, Takeuchi, Jun, Sandy, John D, Plaas, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446537/
https://www.ncbi.nlm.nih.gov/pubmed/22721434
http://dx.doi.org/10.1186/ar3887
_version_ 1782243999551062016
author Li, Jun
Gorski, Daniel J
Anemaet, Wendy
Velasco, Jennifer
Takeuchi, Jun
Sandy, John D
Plaas, Anna
author_facet Li, Jun
Gorski, Daniel J
Anemaet, Wendy
Velasco, Jennifer
Takeuchi, Jun
Sandy, John D
Plaas, Anna
author_sort Li, Jun
collection PubMed
description INTRODUCTION: The mechanism by which intra-articular injection of hyaluronan (HA) ameliorates joint pathology is unknown. Animal studies have shown that HA can reduce synovial activation, periarticular fibrosis and cartilage erosion; however, its specific effects on the different cell types involved remain unclear. We have used the TTR (TGFbeta1 injection and Treadmill Running) model of murine osteoarthritis (OA), which exhibits many OA-like changes, including synovial activation, to examine in vivo tissue-specific effects of intra-articular HA. METHODS: The kinetics of clearance of fluorotagged HA from joints was examined with whole-body imaging. Naïve and treated knee joints were examined macroscopically for cartilage erosion, meniscal damage and fibrosis. Quantitative histopathology was done with Safranin O for cartilage and with Hematoxylin & Eosin for synovium. Gene expression in joint tissues for Acan, Col1a1, Col2a1, Col3a1, Col5a1, Col10a1, Adamts5 and Mmp13 was done by quantitative PCR. The abundance and distribution of aggrecan, collagen types I, II, III, V and X, ADAMTS5 and MMP13 were examined by immunohistochemistry. RESULTS: Injected HA showed a half-life of less than 2 h in the murine knee joint. At the tissue level, HA protected against neovascularization and fibrosis of the meniscus/synovium and maintained articular cartilage integrity in wild-type but not in Cd44 knockout mice. HA injection enhanced the expression of chondrogenic genes and proteins and blocked that of fibrogenic/degradative genes and proteins in cartilage/subchondral bone, whereas it blocked activation of both groups in meniscus/synovium. In all locations it reduced the expression/protein for Mmp13 and blocked Adamts5 expression but not its protein abundance in the synovial lining. CONCLUSIONS: The injection of HA, 24 h after TGFbeta1 injection, inhibited the cascade of OA-like joint changes seen after treadmill use in the TTR model of OA. In terms of mechanism, tissue protection by HA injection was abrogated by Cd44 ablation, suggesting that interaction of the injected HA with CD44 is central to its protective effects on joint tissue remodeling and degeneration in OA progression.
format Online
Article
Text
id pubmed-3446537
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34465372012-09-20 Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism Li, Jun Gorski, Daniel J Anemaet, Wendy Velasco, Jennifer Takeuchi, Jun Sandy, John D Plaas, Anna Arthritis Res Ther Research Article INTRODUCTION: The mechanism by which intra-articular injection of hyaluronan (HA) ameliorates joint pathology is unknown. Animal studies have shown that HA can reduce synovial activation, periarticular fibrosis and cartilage erosion; however, its specific effects on the different cell types involved remain unclear. We have used the TTR (TGFbeta1 injection and Treadmill Running) model of murine osteoarthritis (OA), which exhibits many OA-like changes, including synovial activation, to examine in vivo tissue-specific effects of intra-articular HA. METHODS: The kinetics of clearance of fluorotagged HA from joints was examined with whole-body imaging. Naïve and treated knee joints were examined macroscopically for cartilage erosion, meniscal damage and fibrosis. Quantitative histopathology was done with Safranin O for cartilage and with Hematoxylin & Eosin for synovium. Gene expression in joint tissues for Acan, Col1a1, Col2a1, Col3a1, Col5a1, Col10a1, Adamts5 and Mmp13 was done by quantitative PCR. The abundance and distribution of aggrecan, collagen types I, II, III, V and X, ADAMTS5 and MMP13 were examined by immunohistochemistry. RESULTS: Injected HA showed a half-life of less than 2 h in the murine knee joint. At the tissue level, HA protected against neovascularization and fibrosis of the meniscus/synovium and maintained articular cartilage integrity in wild-type but not in Cd44 knockout mice. HA injection enhanced the expression of chondrogenic genes and proteins and blocked that of fibrogenic/degradative genes and proteins in cartilage/subchondral bone, whereas it blocked activation of both groups in meniscus/synovium. In all locations it reduced the expression/protein for Mmp13 and blocked Adamts5 expression but not its protein abundance in the synovial lining. CONCLUSIONS: The injection of HA, 24 h after TGFbeta1 injection, inhibited the cascade of OA-like joint changes seen after treadmill use in the TTR model of OA. In terms of mechanism, tissue protection by HA injection was abrogated by Cd44 ablation, suggesting that interaction of the injected HA with CD44 is central to its protective effects on joint tissue remodeling and degeneration in OA progression. BioMed Central 2012 2012-06-21 /pmc/articles/PMC3446537/ /pubmed/22721434 http://dx.doi.org/10.1186/ar3887 Text en Copyright ©2012 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Jun
Gorski, Daniel J
Anemaet, Wendy
Velasco, Jennifer
Takeuchi, Jun
Sandy, John D
Plaas, Anna
Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title_full Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title_fullStr Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title_full_unstemmed Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title_short Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism
title_sort hyaluronan injection in murine osteoarthritis prevents tgfbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a cd44-dependent mechanism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446537/
https://www.ncbi.nlm.nih.gov/pubmed/22721434
http://dx.doi.org/10.1186/ar3887
work_keys_str_mv AT lijun hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT gorskidanielj hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT anemaetwendy hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT velascojennifer hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT takeuchijun hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT sandyjohnd hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism
AT plaasanna hyaluronaninjectioninmurineosteoarthritispreventstgfbeta1inducedsynovialneovascularizationandfibrosisandmaintainsarticularcartilageintegritybyacd44dependentmechanism